计算生物学
药物发现
人工智能
计算机科学
抗菌肽
基因组
药物开发
数据科学
深度学习
生物
大数据
重大挑战
对接(动物)
序列(生物学)
生成语法
计算模型
抗菌剂
工程类
纳米技术
抗生素耐药性
化学空间
生物信息学
作者
Tope Abraham Ibisanmi,Xiaotao Jiang,Mark D. P. Willcox,Naresh Kumar
标识
DOI:10.3389/fbinf.2026.1749404
摘要
The accelerating antimicrobial resistance (AMR) crisis continues to render more and more conventional antibiotics ineffective. Antimicrobial peptides (AMPs) are promising alternatives to traditional antibiotics due to their broad-spectrum activity, diverse mechanisms of action, and lower propensity for resistance. Traditional discovery approaches face limitations arising from the vast sequence space and the challenge of balancing efficacy with low toxicity. Addressing these challenges is critical for developing next-generation antimicrobial agents, and computational methods are increasingly driving progress. Public repositories, and techniques such as molecular docking enable in silico evaluation of peptide target interactions, identifying candidates with strong binding potential. Molecular dynamics (MD) simulations offer deeper insights into how AMPs disrupt membranes, form pores, or act synergistically, while Steered MD extends this to probing membrane penetration. Artificial intelligence (AI) methods, including machine learning and deep learning, capture complex sequence activity relationships, predict novel AMPs from genomic and metagenomic data, and design new peptides de novo using generative models. Despite rapid advances, most existing reviews treat these approaches in isolation, leaving a fragmented understanding of their interplay. This paper addresses that gap by unifying computational strategies, highlighting synergies, and critiquing limitations. Ultimately, integrating these methodologies offers a path toward more efficient AMP discovery to fight AMR.
科研通智能强力驱动
Strongly Powered by AbleSci AI